Apyx Medical (NASDAQ:APYX – Get Rating) posted its quarterly earnings data on Thursday. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.02), MarketWatch Earnings reports. Apyx Medical had a negative net margin of 31.27% and a negative return on equity of 26.79%. During the same quarter in the previous year, the firm earned ($0.14) earnings per share. Apyx Medical updated its FY 2022 guidance to EPS.
NASDAQ:APYX opened at $3.65 on Friday. The stock has a 50 day moving average of $5.76 and a 200-day moving average of $10.14. Apyx Medical has a 52 week low of $3.01 and a 52 week high of $17.50.
Several analysts have recently weighed in on the company. Colliers Securities restated a “buy” rating on shares of Apyx Medical in a research note on Tuesday, March 22nd. Zacks Investment Research downgraded Apyx Medical from a “hold” rating to a “sell” rating in a research note on Friday. Finally, Piper Sandler lowered their target price on Apyx Medical from $12.00 to $6.00 in a research note on Thursday.
About Apyx Medical (Get Rating)
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures.
- Get a free copy of the StockNews.com research report on Apyx Medical (APYX)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Want More Great Investing Ideas?
- 3 Stocks to DOUBLE This Year
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 9 "MUST OWN" Growth Stocks
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.